Product Description:

• Somatuline Autogel is an extended-release pharmaceutical form of lanreotide.Lanreotide is an octapeptide, an analogue of the natural hormone somatostatin.
• Lanreotide decreases the concentration of hormones in the body, such as GH (growth hormone) and IGF-1 (insulin-like growth factor 1) and inhibits certain digestive hormones and intestinal secretions.
• Somatuline Autogel is recommended for the treatment of acromegaly and certain diseases affecting the intestine.

How to use:

• For the treatment of acromegaly or the symptoms of carcinoid syndrome, the recommended starting dose is 60 mg to 120 mg injected every 28 days. Depending on your response to the product, your doctor may vary the dose or the injection frequency. Your doctor will also decide on the length of your treatment.
• For the treatment of advanced tumours of the intestine and pancreas that cannot be removed by surgery (gastroenteropancreatic neuroendocrine tumours - GEP-NETs), the recommended dose is 120mg every 28 days. Your doctor will decide how long you should be treated with Somatuline Autogel for tumour control.

Caution & Warnings:

Do not be given Somatuline Autogel if:

• you are breastfeeding
• you have a tumour blocking your intestines
• you are allergic to lanreotide, the active ingredient of Somatuline Autogel.

Side Effects:

• Intestinal disorders including diarrhea or loose stools, abdominal pain, flatulence and constipation
• Inflammation or sensitivity.
• In the case of prolonged treatment, gall bladder stones may occur (lithiasis)
• If you are diabetic, your doctor may check your blood sugar level and change your anti-diabetic treatment during treatment with Somatuline Autogel.

Ingredients:

• lanreotide acetate 120Mg.